Press Releases 2018 2019 2020 2021 2022 2023 2024 2025 2026 No results found News, Press Releases MacDougall Creative 12/17/21 News, Press Releases MacDougall Creative 12/17/21 OncoNano Medicine Appoints Brett Giroir, M.D., to Board of Directors Read More Press Releases MacDougall Creative 10/25/21 Press Releases MacDougall Creative 10/25/21 $18.4 Million Equity Investment by the Cancer Prevention and Research Institute of Texas Read More News, Press Releases MacDougall Creative 10/14/21 News, Press Releases MacDougall Creative 10/14/21 Pegsitacianine Demonstrates Tumor-Agnostic Real-Time Surgical Imaging in Phase 2 Study Read More News, Press Releases MacDougall Creative 10/8/21 News, Press Releases MacDougall Creative 10/8/21 Positive Preclinical Data for ONM-501 at AACR Virtual Conference Read More News, Press Releases MacDougall Creative 9/30/21 News, Press Releases MacDougall Creative 9/30/21 Present at The American Association for Cancer Research Virtual Conference Read More Press Releases MacDougall Creative 9/22/21 Press Releases MacDougall Creative 9/22/21 Expanded Research Collaboration with UT Southwestern Medical Center Read More Press Releases MacDougall Creative 9/20/21 Press Releases MacDougall Creative 9/20/21 OncoNano Medicine to Present at The World Molecular Imaging Congress Read More News MacDougall Creative 7/22/21 News MacDougall Creative 7/22/21 OncoNano Medicine Raises ~$50 Million in Series B Financing Read More Press Releases MacDougall Creative 7/19/21 Press Releases MacDougall Creative 7/19/21 OncoNano Medicine to Present at the 2nd Annual LifeSci Partners Private Company Summer Symposium Read More Press Releases MacDougall Creative 6/17/21 Press Releases MacDougall Creative 6/17/21 OncoNano Medicine Raises ~$50 Million in Series B Financing Read More Press Releases MacDougall Creative 3/31/21 Press Releases MacDougall Creative 3/31/21 OncoNano Awarded $15.4 Million Grant Read More Press Releases MacDougall Creative 3/31/21 Press Releases MacDougall Creative 3/31/21 Publication of ONM-100 Phase 1 Read More Press Releases MacDougall Creative 2/10/21 Press Releases MacDougall Creative 2/10/21 Study Reveals Compelling Data for a New Nanoparticle-based Immuno-Therapeutic to Treat Cancer Read More Press Releases MacDougall Creative 2/9/21 Press Releases MacDougall Creative 2/9/21 Study Reveals Compelling Data for a New Nanoparticle-based Immuno-Therapeutic to Treat Cancer Read More News MacDougall Creative 2/1/21 News MacDougall Creative 2/1/21 OncoNano Medicine Announces Martin Driscoll as CEO Read More
News, Press Releases MacDougall Creative 12/17/21 News, Press Releases MacDougall Creative 12/17/21 OncoNano Medicine Appoints Brett Giroir, M.D., to Board of Directors Read More
Press Releases MacDougall Creative 10/25/21 Press Releases MacDougall Creative 10/25/21 $18.4 Million Equity Investment by the Cancer Prevention and Research Institute of Texas Read More
News, Press Releases MacDougall Creative 10/14/21 News, Press Releases MacDougall Creative 10/14/21 Pegsitacianine Demonstrates Tumor-Agnostic Real-Time Surgical Imaging in Phase 2 Study Read More
News, Press Releases MacDougall Creative 10/8/21 News, Press Releases MacDougall Creative 10/8/21 Positive Preclinical Data for ONM-501 at AACR Virtual Conference Read More
News, Press Releases MacDougall Creative 9/30/21 News, Press Releases MacDougall Creative 9/30/21 Present at The American Association for Cancer Research Virtual Conference Read More
Press Releases MacDougall Creative 9/22/21 Press Releases MacDougall Creative 9/22/21 Expanded Research Collaboration with UT Southwestern Medical Center Read More
Press Releases MacDougall Creative 9/20/21 Press Releases MacDougall Creative 9/20/21 OncoNano Medicine to Present at The World Molecular Imaging Congress Read More
News MacDougall Creative 7/22/21 News MacDougall Creative 7/22/21 OncoNano Medicine Raises ~$50 Million in Series B Financing Read More
Press Releases MacDougall Creative 7/19/21 Press Releases MacDougall Creative 7/19/21 OncoNano Medicine to Present at the 2nd Annual LifeSci Partners Private Company Summer Symposium Read More
Press Releases MacDougall Creative 6/17/21 Press Releases MacDougall Creative 6/17/21 OncoNano Medicine Raises ~$50 Million in Series B Financing Read More
Press Releases MacDougall Creative 3/31/21 Press Releases MacDougall Creative 3/31/21 OncoNano Awarded $15.4 Million Grant Read More
Press Releases MacDougall Creative 3/31/21 Press Releases MacDougall Creative 3/31/21 Publication of ONM-100 Phase 1 Read More
Press Releases MacDougall Creative 2/10/21 Press Releases MacDougall Creative 2/10/21 Study Reveals Compelling Data for a New Nanoparticle-based Immuno-Therapeutic to Treat Cancer Read More
Press Releases MacDougall Creative 2/9/21 Press Releases MacDougall Creative 2/9/21 Study Reveals Compelling Data for a New Nanoparticle-based Immuno-Therapeutic to Treat Cancer Read More
News MacDougall Creative 2/1/21 News MacDougall Creative 2/1/21 OncoNano Medicine Announces Martin Driscoll as CEO Read More